Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Winningham Rick E
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,686,408    

Indirect Shares

   96,467      
Direct Value   $32,096,465    

Indirect Value

   $926,083      
Total Shares   2,782,875      
Total Value   $33,022,548      


Innoviva Inc $13,189,748 Jazz Pharmaceuticals Inc $1,141,216 Theravance Biopharma, Inc. $17,765,501 Innoviva Inc $13,189,748 Jazz Pharmaceuticals Inc $1,141,216 Theravance Biopharma, Inc. $17,765,501
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -15.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Innoviva Inc INVA Director 2014-08-15 825,391 2008-01-29 0    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 10,444 2012-01-11 0    Premium*  
            Theravance Biopharma, Inc. TBPH 2024-04-02 1,850,573 2024-04-02 96,467    Premium*  
* Premium Members only  

Records found :    130         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2019-02-20 4 D $27.00 $363,879 D/D (13,477) 1,099,462 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2019-05-20 4 D $19.84 $172,172 D/D (8,678) 1,091,811 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2019-08-20 4 D $21.51 $186,664 D/D (8,678) 1,083,133 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2019-11-20 4 D $17.60 $152,733 D/D (8,678) 1,074,455 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-02-03 4 A $0.00 $0 D/D 338,000 1,412,455 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-02-20 4 D $25.90 $2,508,415 D/D (96,850) 1,315,605 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-05-20 4 D $26.67 $371,940 D/D (13,946) 1,303,061 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-08-20 4 D $18.22 $254,096 D/D (13,946) 1,289,115 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-11-20 4 D $17.21 $240,011 D/D (13,946) 1,275,169 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2021-02-08 4 A $0.00 $0 D/D 170,000 1,445,169 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2021-02-20 4 D $18.79 $2,073,439 D/D (110,348) 1,334,821 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2021-05-20 4 D $17.80 $202,991 D/D (11,404) 1,324,818 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2021-08-20 4 D $14.05 $160,226 D/D (11,404) 1,313,414 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-02-18 4 D $9.61 $218,243 D/D (22,710) 1,279,300 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-02-25 4 A $0.00 $0 D/D 170,000 1,449,300 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-05-20 4 D $8.74 $96,359 D/D (11,025) 1,440,588 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-08-19 4 D $9.34 $147,609 D/D (15,804) 1,424,784 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-11-20 4 D $10.85 $171,473 D/D (15,804) 1,409,797 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-12-13 4 GD $0.00 $0 D/D 9,000 1,400,797 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-12-14 4 S $11.19 $559,500 D/D (50,000) 1,350,797 0 %
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-02-20 4 D $10.44 $390,665 D/D (37,420) 1,313,377 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-03-01 4 A $0.00 $0 D/D 330,000 1,643,377 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-05-20 4 D $11.21 $177,163 D/D (15,804) 1,627,573 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-20 4 D $9.70 $153,299 D/D (15,804) 1,611,769 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-11-20 4 D $10.37 $163,887 D/D (15,804) 1,595,965 0 -
  130  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us